Test Code LAB4108 HDL CHOLESTEROL
Additional Codes
Labcorp 001925
Specimen Type
Preferred Sample: Lithium Heparin Plasma (Mint Green Top, Dark Green Top)
Alternate Sample: Serum (SST, Gold, Corvac, Tiger, Red Top Tube)
Specimen Volume
1 mL
Minimum Volume
0.5 mL
Turnaround Time
STAT: 1 hour
Routine: 4 hours
Test Schedule
Daily
Sample Stability
Room Temp: 2 days
Refrigerated: 7 days
Frozen: 3 months
Method
Colorimetric
Reference Ranges
HDL mg/dL
Less than 40 Low
40-59 Within normal limits
60 or more High
HDL Cholesterol greater than or equal to 60 mg/dL is considered to be a ‘negative’ risk factor, serving to remove one risk factor from the total count.
Critical Value: None
Reportable Range: 5 - 180 mg/dL
Synonyms
High Density Lipoprotein
CPT Codes
83718
Test Components
HDL, mg/dL
Specimen Processing
Do not use specimens that have been ultracentrifuged.
Clinical Information
Plasma lipoproteins are spherical particles containing varying amounts of cholesterol, triglycerides, phospholipids, and proteins. Phospholipids, free cholesterol, and proteins constitute the outer surface of the lipoprotein particle, while the inner core contains mostly esterified cholesterol and triglyceride in the blood stream. The relative proportions of the protein and the lipid determine the density of these lipoproteins and provide a basis on which to begin their classification. The classes are chylomicron, very-low-density lipoprotein (VLDL), low-density lipoprotein (LDL), and high-density lipoprotein (HDL). Numerous clinical studies have shown that the different classes have very distinct and varied effects on coronary heart disease risk.
The principle role of HDL cholesterol in lipid metabolism is the uptake and transport of cholesterol from peripheral tissues to the liver through a process known as reverse cholesterol transport (a proposed cardioprotective mechanism). Low HDL cholesterol levels are strongly associated with an increased risk of coronary heart disease.
The determination of serum HDL cholesterol is a useful tool in identifying high-risk patients. The Adult Treatment Panel of the National Cholesterol Education Program (NCEP) recommends that in all adults 20 years of age and over should obtain a fasting lipoprotein profile once every five years to screen for coronary heart disease.